4-androstene-3,17-diol has been researched along with ovalbumin in 1 studies
| Studies (4-androstene-3,17-diol) | Trials (4-androstene-3,17-diol) | Recent Studies (post-2010) (4-androstene-3,17-diol) | Studies (ovalbumin) | Trials (ovalbumin) | Recent Studies (post-2010) (ovalbumin) |
|---|---|---|---|---|---|
| 13 | 1 | 2 | 19,565 | 63 | 5,664 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bagchus, WM; Bakker, JM; Kraal, G; Wolvers, DA | 1 |
1 other study(ies) available for 4-androstene-3,17-diol and ovalbumin
| Article | Year |
|---|---|
The steroid hormone dehydroepiandrosterone (DHEA) breaks intranasally induced tolerance, when administered at time of systemic immunization.
Topics: Administration, Intranasal; Androstenediols; Androstenols; Animals; Antibodies; Antibody Formation; Dehydroepiandrosterone; Hypersensitivity, Delayed; Immune Tolerance; Immunization; Male; Mice; Mice, Inbred BALB C; Ovalbumin | 1998 |